Cardiovascular risk profiles in patients with primary sclerosing cholangitis
One-third of PSC patients exhibit nonideal CVH, particularly PSC-IBD patients. In this cohort, 10% had prior ASCVD with mostly modifiable risk factors at time of the event. These findings suggest that PSC patients might benefit from proactive ASCVD surveillance and risk management.
Authors
- A.C. de Vries
- C. Janneke van der Woude (ORCID: https://orcid.org/0000-0003-3875-6957)
- JE Roeters van Lennep
- AJ van der Meer
- J.A.M. Sleutjes
- N. van de Pol
- R.A. de Man
Institutions
- Radboud University Nijmegen (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1097/meg.0000000000003146
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00